EV MemProt Atlas

Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40

	UniProt ID	Protein names	Protein classification	Transmembrane count	Related Diseases	Mediation categories
SCN3B	Q9NY72	Sodium channel regulatory subunit beta-3		1		Fusion and delivery mediation	3	0.50
SHRM2	Q13796	Protein Shroom2 (Apical-like protein) (Protein APXL)	Plasma proteinsPredicted intracellular proteins			Fusion and delivery mediation	3	0.50
SMAGP	Q0VAQ4	Small cell adhesion glycoprotein (Small transmembrane and glycosylated protein)	Predicted intracellular proteinsPredicted membrane proteins	1		Other mediation	3	0.50
SMAP1	Q8IYB5	Stromal membrane-associated protein 1	Predicted intracellular proteins			Adhesion and uptake mediationImmune mediationMetabolism mediation	3	0.50
TAU	P10636	Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau)	Candidate cardiovascular disease genesDisease related genesFDA approved drug targets		Acute myeloid leukaemiaAlzheimer diseaseCentral nervous system disease	Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation	3	0.50
TBC30	Q9Y2I9	TBC1 domain family member 30	Predicted intracellular proteinsPredicted membrane proteins			Receptor-signaling mediation	3	0.50
TCHP	Q9BT92	Trichoplein keratin filament-binding protein (Protein TCHP) (Mitochondrial protein with oncostatic activity) (Mitostatin) (Tumor suppressor protein)	Predicted intracellular proteins			Fusion and delivery mediation	3	0.50
TM252	Q8N6L7	Transmembrane protein 252	Predicted membrane proteins	2		Other mediation	3	0.50
TM254	Q8TBM7	Transmembrane protein 254	Predicted membrane proteins	3		Other mediation	3	0.50
TM268	Q5VZI3	Transmembrane protein 268	Predicted membrane proteins	2		Other mediation	3	0.50
TM50A	O95807	Transmembrane protein 50A (Small membrane protein 1)		4		Other mediation	3	0.50
TNR16	P08138	Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (Low-affinity nerve growth factor receptor p75NGFR) (Low-affinity nerve growth factor receptor p75NGR) (p75 ICD) (CD antigen CD271)	Cancer-related genesCD markersPredicted intracellular proteins	1	Alzheimer diseaseCerebral ischaemiaChronic pain	Clinical-translation mediationMetabolism mediationReceptor-signaling mediation	3	0.50
ZDHC5	Q9C0B5	Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375)	EnzymesMetabolic proteinsPlasma proteins	4		Clinical-translation mediationFusion and delivery mediationImmune mediation	3	0.50
4F2	P08195	Amino acid transporter heavy chain SLC3A2 (4F2 cell-surface antigen heavy chain) (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98)	Cancer-related genesCD markersEssential proteins	1	Acute myeloid leukaemia	Clinical-translation mediationFusion and delivery mediationImmune mediation	2	0.50
5HT1B	P28222	5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)	FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins	7	Alzheimer diseaseAnxiety disorderAttention deficit hyperactivity disorder	Clinical-translation mediationFusion and delivery mediationMetabolism mediation	2	0.50
5HT7R	P34969	5-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (5-HT-X) (Serotonin receptor 7)	FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins	7	Alzheimer diseaseAttention deficit hyperactivity disorderBipolar disorder	Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation	2	0.50
AA2BR	P29275	Adenosine receptor A2b		7	Alzheimer diseaseAsthmaBreathing abnormality	Clinical-translation mediationFusion and delivery mediationImmune mediation	2	0.50
ACHA3	P32297	Neuronal acetylcholine receptor subunit alpha-3	Disease related genesFDA approved drug targetsPredicted intracellular proteins	4		Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation	2	0.50
ACK1	Q07912	Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2)	Cancer-related genesEnzymesPlasma proteins			Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation	2	0.50
ACM3	P20309	Muscarinic acetylcholine receptor M3	Disease related genesFDA approved drug targetsG-protein coupled receptors	7	Abnormal micturitionAlzheimer diseaseAsthma	Clinical-translation mediationFusion and delivery mediationMetabolism mediation	2	0.50
ACOT9	Q9Y305	Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (EC 3.1.2.2) (Acyl-CoA thioester hydrolase 9)	Metabolic proteinsPredicted intracellular proteins			Metabolism mediation	2	0.50
ADAP1	O75689	Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25)	Predicted intracellular proteins			Receptor-signaling mediation	2	0.50
ANO2	Q9NQ90	Anoctamin-2 (Transmembrane protein 16B)	Predicted membrane proteinsTransporters	8		Clinical-translation mediationFusion and delivery mediation	2	0.50
ANO6	Q4KMQ2	Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F)	Disease related genesHuman disease related genesPotential drug targets	10		Clinical-translation mediationFusion and delivery mediationImmune mediation	2	0.50
ANRA2	Q9H9E1	Ankyrin repeat family A protein 2 (RFXANK-like protein 2)	Predicted intracellular proteins			Other mediation	2	0.50